Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies

Bibliographic Details
Main Authors: Ingle, J, Dowsett, M, Cuzick, J, Davies, C
Format: Conference item
Published: 2009
_version_ 1797069514196647936
author Ingle, J
Dowsett, M
Cuzick, J
Davies, C
author_facet Ingle, J
Dowsett, M
Cuzick, J
Davies, C
author_sort Ingle, J
collection OXFORD
description
first_indexed 2024-03-06T22:25:35Z
format Conference item
id oxford-uuid:5692a7b4-eee8-4c0c-b416-e34360117778
institution University of Oxford
last_indexed 2024-03-06T22:25:35Z
publishDate 2009
record_format dspace
spelling oxford-uuid:5692a7b4-eee8-4c0c-b416-e343601177782022-03-26T16:51:00ZAromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategiesConference itemhttp://purl.org/coar/resource_type/c_5794uuid:5692a7b4-eee8-4c0c-b416-e34360117778Symplectic Elements at Oxford2009Ingle, JDowsett, MCuzick, JDavies, C
spellingShingle Ingle, J
Dowsett, M
Cuzick, J
Davies, C
Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies
title Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies
title_full Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies
title_fullStr Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies
title_full_unstemmed Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies
title_short Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies
title_sort aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer meta analyses of randomized trials of monotherapy and switching strategies
work_keys_str_mv AT inglej aromataseinhibitorsversustarnoxifenasadjuvanttherapyforpostmenopausalwomenwithestrogenreceptorpositivebreastcancermetaanalysesofrandomizedtrialsofmonotherapyandswitchingstrategies
AT dowsettm aromataseinhibitorsversustarnoxifenasadjuvanttherapyforpostmenopausalwomenwithestrogenreceptorpositivebreastcancermetaanalysesofrandomizedtrialsofmonotherapyandswitchingstrategies
AT cuzickj aromataseinhibitorsversustarnoxifenasadjuvanttherapyforpostmenopausalwomenwithestrogenreceptorpositivebreastcancermetaanalysesofrandomizedtrialsofmonotherapyandswitchingstrategies
AT daviesc aromataseinhibitorsversustarnoxifenasadjuvanttherapyforpostmenopausalwomenwithestrogenreceptorpositivebreastcancermetaanalysesofrandomizedtrialsofmonotherapyandswitchingstrategies